MORGAN STANLEY

Position in NTLA — Intellia Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$29,303,828

+$2,620,324 QoQ

Shares Held

1,731,905

-16.8% QoQ

Ownership

1.24%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 330 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 73% Shared 0% None 27%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NTLA ranks #77 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

All Filings in NTLA

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,303,828	1,731,905	-16.8%	Shares	Defined	2026-08-13
2026-03-31	$26,683,504	2,081,397	-10.6%	Shares	Defined	2026-05-15
2025-12-31	$20,927,386	2,327,852	-61.3%	Shares	Defined	2026-05-27
2025-09-30	$104,009,882	6,022,576	+46.3%	Shares	Defined	2026-05-27
2025-06-30	$38,616,152	4,116,861	+8.3%	Shares	Defined	2025-08-15
2025-03-31	$27,030,047	3,801,695	-0.3%	Shares	Defined	2025-05-15
2024-12-31	$44,477,599	3,814,546	+48.1%	Shares	Defined	2025-05-15
2024-09-30	$52,937,493	2,576,034	+10.2%	Shares	Defined	2025-05-14
2024-06-30	$52,317,921	2,337,709	-11.6%	Shares	Defined	2025-05-14
2024-03-31	$72,759,847	2,644,851	+3.9%	Shares	Defined	2024-10-17
2023-12-31	$77,597,715	2,545,022	-17.7%	Shares	Defined	2024-08-16
2023-09-30	$97,735,548	3,090,941	+8.5%	Shares	Defined	2023-11-15
2023-06-30	$116,190,657	2,849,207	+7.3%	Shares	Defined	2023-08-14
2023-03-31	$98,969,846	2,655,483	+5.5%	Shares	Defined	2023-05-15
2022-12-31	$87,858,249	2,518,150	+64.5%	Shares	Defined	2023-02-14
2022-09-30	$85,649,629	1,530,551	+23.8%	Shares	Defined	2022-11-14
2022-06-30	$63,985,396	1,236,194	-4.5%	Shares	Defined	2022-08-15
2022-03-31	$94,107,573	1,294,999	-15.0%	Shares	Defined	2022-05-13
2021-12-31	$180,109,431	1,523,253	+32.9%	Shares	Defined	2022-02-14
2021-09-30	$153,741,129	1,146,039	+64.3%	Shares	Defined	2021-11-15
2021-06-30	$112,968,328	697,723	+38.1%	Shares	Defined	2021-08-23
2021-03-31	$40,555,255	505,330	-57.0%	Shares	Defined	2021-05-17
2020-12-31	$63,999,150	1,176,455	-0.9%	Shares	Defined	2021-02-16
2020-09-30	$23,594,238	1,186,833	+52.2%	Shares	Defined	2020-11-13
2020-06-30	$16,395,409	779,991	+20.2%	Shares	Defined	2020-08-14
2020-03-31	$7,935,458	648,852	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.